Keyphrases
Endometrial Cancer
97%
Tumor
64%
Endometrial Carcinoma
61%
ETV5
43%
Ovarian Cancer
41%
Transcription Factor
27%
MicroRNA
25%
Epithelial-to-mesenchymal Transition
22%
Papillary Thyroid Carcinoma
22%
Chemoresistance
21%
Molecular Profiling
20%
Overexpression
19%
Immunohistochemistry
19%
Gynecologic Malignancies
18%
Molecular Profile
18%
Infiltration
18%
B Lymphocytes
17%
Myometrial Infiltration
16%
Lymph Node Metastasis
16%
Signaling Pathway
16%
Ovarian Cancer Cells
16%
Fluorescence in Situ Hybridization
16%
Lgr5+
16%
Eutopic Endometrium
16%
High-grade Serous Ovarian Cancer (HGSOC)
16%
Rituximab
16%
P16INK4a
16%
Cervical mucus
16%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
16%
Carcinoma
15%
Endometrioid
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
14%
Primary Central Nervous System Lymphoma (PCNSL)
13%
Metastasis
13%
Endometriosis
13%
In Cancer
13%
Clinical Data
13%
Endometrioid Endometrial Cancer
13%
Gene Expression
12%
Viral Reactivation
12%
CD32
12%
Squamous Intraepithelial Lesion
12%
Malignancy
11%
T Cells
11%
HIV Reservoir
11%
Female Genital Tract
11%
Poor Prognosis
10%
Molecular Pathology
10%
Endometrium
10%
Lgr5
10%
Medicine and Dentistry
Uterine Cancer
100%
Endometrium Carcinoma
77%
Tumor
63%
Ovarian Cancer
48%
Cancer
34%
Neoplasm
30%
Transcription Factors
29%
Recurrent Disease
28%
Carcinogenesis
27%
Mesenchymal-Epithelial Transition
25%
Proteomics
24%
Papillary Thyroid Cancer
24%
Diseases
24%
Cancer Cell
23%
Drug Resistance
23%
Metastatic Carcinoma
17%
microRNA
17%
Cell Signaling Pathway
17%
Head and Neck Squamous Cell Carcinoma
16%
B Lymphocyte
16%
Diffuse Large B-Cell Lymphoma
15%
Gene Expression
15%
Carcinoma
15%
Lymph Node Metastasis
14%
Upregulation
13%
Lymph Node
13%
Molecular Profiling
12%
B Cell
12%
Protein P53
11%
Molecular Pathology
11%
Biological Marker
11%
Retroperitoneal Lymph Node Dissection
11%
Protein Kinase B
11%
Biopsy Technique
10%
Serous Carcinoma
10%
Cancer Stem Cell
9%
Signal Transduction
9%
Lymph Duct
9%
Endometrium
9%
Cell Proliferation
9%
Molecular Classification
8%
Malignant Neoplasm
8%
Immunohistochemistry
8%
Human Immunodeficiency Virus
8%
B-Cell Lymphoma
8%
Cell Adhesion
8%
P16
8%
Clear Cell Carcinoma
8%
Cyclin Dependent Kinase Inhibitor
8%
Circulating Tumor Cell
8%